StemPoint Capital LP 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 12:01 pm Purchase | 2026-06-30 | 13G | XILIO THERAPEUTICS INC XLO | StemPoint Capital LP | 628,866 9.500% | 198,150 (+46.00%) | Filing |